Donor Blood Components Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component (Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others), Indication (Immunosuppress

According to our new research study on “Donor Blood Component Market Forecast to 2031 -Global Analysis - by Blood Component, Indication, Application, Age Group, and Geography,” the market is anticipated to grow from US$ 10.08 billion in 2024 and is projected to reach US$ 14.64 billion by 2031; it is expected to register a CAGR of 5.7% during 2025-2031. Rising prevalence of cancer and immunosuppressive diseases, and increasing donor awareness are contributing to the growing donor blood component market size. However, the inconsistent voluntary donations hamper the donor blood component market growth. Further, rising demand for plasma-derived therapies are expected to bring in new donor blood component market trends in the coming years.

The donor blood components market is one of the prominent segments of the healthcare industry, driven by the increasing need for safe transfusions during surgery, trauma, cancer treatment, and chronic disease. Donor blood components include red blood cells (RBCs), plasma, platelets, and cryoprecipitate. The donor blood components market growth is being propelled by rising global awareness, aging populations, and growing advancements in collection and storage technologies. However, issues such as low rates of voluntary donations in certain regions, regulatory issues, and logistical limitations remain. New technologies such as apheresis and pathogen reduction systems are improving product safety and efficiency. Furthermore, government and NGO initiatives to increase regular, voluntary blood donation are increasing the donor base. The market has great potential, particularly in evolving healthcare systems.

Donor Blood Component Market Analysis

Emerging Market Demand to Provide Market Opportunities in Future

Emerging economies, particularly in Southeast Asia, Latin America, and some regions in Africa, offer a strong growth opportunity for the donor blood component market. As healthcare infrastructure in these economies grows, investment in blood donation facilities is emerging as a strategic imperative. In Argentina, Brazil, and Mexico, voluntary donations voluntary donation programs have gained significant traction: Latin America received more than 9.2 million units in 2023, a 15.5% increase over 2020, with 56.8% of donations voluntary due to mobile drives and online campaigns. This growth represents the collaborative coordination of awareness campaigns and public-private alliances that have had on national blood systems. Similarly, in Indonesia, for instance, corporate donors such as Asian Agri initiated regional Blood Donation Weeks, accumulating hundreds of units from rural provinces. In June 2024, they engaged 414 donors and collected 287 units from three provinces, contributing to inventory and awareness. These private-sector cooperation enhances community trust and donor participation.

According to the WHO, the demand for blood products is projected to increase 5% each year in developing nations. To respond to the demand, the nations are focusing on the modernization of infrastructure, such as Indonesia's new plasma-fractionation factory and increased mobile blood collections in Africa. Technological utilization in the form of apheresis equipment, NAT testing, and automation processing is enhancing safety and public trust.

The convergence of growing medical demand, increasing voluntary donation, digital outreach, and regulatory reforms positions emerging markets for growth in donor blood services. Developments in these systems not only meet increasing clinical need but also catalyze long-term sustainability in the global donor blood component market.

Donor Blood Component Market Report Segmentation Analysis

Key segments that contributed to the derivation of the donor blood component market analysis are product, device type, application, age group, gender, and end user.
Based on blood component, the donor blood components market is segmented into red blood cells, white blood cells, platelets, plasma, and others. The red blood cells segment held the largest share of the market in 2024.
By indication, the donor blood components market is bifurcated into immunosuppression and oncology. The immunosuppression segment dominated the market in 2024.
In terms of application, the donor blood components market is segmented into anemia management, thrombocytopenia treatment, coagulopathy correction, supportive care during chemotherapy, surgery, and others. The anemia management segment held the largest share of the market in 2024.
By age group, the donor blood components market is bifurcated into adult and child. The adult segment dominated the market in 2024.
As per end user, the donor blood components market is categorized into hospitals, oncology centers, transplant centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2024.

Donor Blood Component Market: Competitive Landscape and Key Developments

Roswell Park Comprehensive Cancer Center, Policlinico of Milan, Vitalant, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, Tata Memorial Hospital, Memorial Sloan Kettering Cancer Center are among the key companies operating in the donor blood component market.

The World Health Organization (WHO), the American Society of Plastic Surgeons, Health Resources and Services Administration, American Cancer Society, The Leukemia & Lymphoma Society, Health Canada, International Agency for Research on Cancer (IARC), Federal Statistical Office (Destatis), Macmillan Cancer Support data, National Health Commission (NHC), Indian Council of Medical Research-National Centre for Disease Informatics and Research (ICMR-NCDIR), Australian Institute of Health and Welfare, Australian Red Cross Lifeblood, GLOBOCAN are among the primary and secondary sources referred to while preparing the donor blood components market report.

Reasons to buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the donor blood components market. 
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the donor blood components market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more